000 01104 a2200301 4500
005 20250516091033.0
264 0 _c20121018
008 201210s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2012.04.052
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrabenstein, John D
245 0 0 _aPneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults.
_h[electronic resource]
260 _bVaccine
_cJun 2012
300 _a4435-44 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAntibodies, Bacterial
_xblood
650 0 4 _aAntibody Formation
650 0 4 _aHumans
650 0 4 _aImmunization, Secondary
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aPneumococcal Vaccines
_xadverse effects
650 0 4 _aTime Factors
700 1 _aManoff, Susan B
773 0 _tVaccine
_gvol. 30
_gno. 30
_gp. 4435-44
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2012.04.052
_zAvailable from publisher's website
999 _c21740363
_d21740363